Market Report, "Iraq Pharmaceuticals & Healthcare Report Q1 2014", Published
Iraq's healthcare and pharmaceuticals market is ripe for investment. Healthcare infrastructure is ageing, or absent, beyond the capital; there is a shortage of trained healthcare personnel; a drug supply chain that is hampered by imports and counterfeit drugs; and a burden of communicable diseases in much of the country. But the security and political risks of operating in this country hang heavily over the market, deterring investors.
View full press release